We have used a tissue culture system based on breast environmental factors may contribute substantially to carcinoma cell lines to investigate a large number of cancer incidence. Excellent recent reviews summarize naturally occurring compounds and beverages for ste-the current knowledge, which was generated by using roid hormone agonist and antagonist activity. The cell cell lines, animal models as well as humans (1-5). The lines used, T-47D and BT-474, produce prostate specific role of endogenous and exogenous steroid hormones in antigen (PSA) upon stimulation with androgens, pro-the development of breast, prostate and other cancers gestins, glucocorticoids and mineralocorticoids. This is well recognized (6-8). More recently, the potential biobiomarker is secreted and can be measured in the tis-logical impact of environmental and dietary estrogens sue culture supernatant with very high sensitivity by on human health has generated considerable interest an immunofluorometric procedure. Steroid hormone (9-13). These agents include phytoestrogens as well as (19,20). Many other natural comthe ability to bind to steroid hormone receptors and act as weak blockers. A fewer number of compounds pounds were also found to have weak estrogenic activity not only bind to the receptors but they also mediate (21) while others, like quercetin, appear to act as antitranscriptional activity, acting as agonists. The ago-carcinogens via different mechanisms one of which nists and antagonists were active at levels around 10 05 is downregulation of mutant oncogenic proteins (22). M, in accordance with previous reports for other phy-There is now a large body of evidence indicating that tochemicals. In comparison to synthetic and natural natural compounds can affect signal transduction pathsteroid hormones, the biological activity of these com-ways, cell proliferation rates and cell differentiation and pounds is weaker by a factor of approximately 10 4 -fold. many of these compounds have hormone-like, antioxi-᭧ 1998 Academic Press dant and antimutagenic activity. Some of these comKey Words: phytoestrogens; phytoprogestins; phy-pounds may have potential for cancer prevention or even toandrogens; steroid hormone receptors; cancer pre-cancer therapy (12, (23) (24) (25) .
Dose-response experiments. For dose-response experiments, we folmones, we have proposed this system as a sensitive tool lowed the same protocol as for the general stimulation experiments for evaluating the biological activity of candidate andro-described above, but the compounds (2 mL per well) were added at gens, progestins, glucocorticoids and mineralocorticoids. various concentrations. The dilution of each stock compound solution Estrogens do not mediate appreciably PSA production in the well was 1000-fold for all experiments. The final concentration of each steroid or compound was used for data interpretation.
in these cell lines. With a modified procedure, we can utilize the same tissue culture system to assess receptor Blocking experiments. Blocking experiments were performed for two reasons: (a) To identify if any of the compounds in Table 1 can blocking activity by first exposing the cells to a candidate block the steroid hormone receptors and thus act as antagonists of blocking compound and then inducing them with a steroid hormone action; (b) To identify if the compounds that can known agonist (progestin or androgen). Any blocking ac-stimulate PSA production in this culture system are candidate androtivity will manifest as an inhibition of the agonist to gens While we have found a number of compounds that can the candidate blocker or the stimulating steroid and the effect of the exhibit blocking activity, the only compounds that candidate blocker on the ability of the stimulating steroid to induce acted as weak agonists in the system were the 7-hy-PSA expression when the blocker is allowed to bind to the receptors at tenfold higher concentration for 1 h before the addition of the droxy flavonoids apigenin and naringenin, and the cinstimulating steroid.
namic acid derivative syringic acid. All three comFor identifying progestational or androgenic activity of the weak pounds appear to behave as weak progestins.
agonists apigenin, naringenin and syringic acid, we used the known steroid hormone receptor blockers mifepristone (antiprogestin) and RU 56187 (antiandrogen) at a concentration of 10 08 M and the weak
MATERIALS AND METHODS
agonists at a concentration of 10 05 M.
Measurement of PSA. PSA was measured in the tissue culture Compounds. The compounds and natural products tested are supernatants with a highly sensitive immunofluorometric procedure shown in table 1. Steroids used for control purposes were obtained described in detail elsewhere (28). This assay can measure PSA at from Sigma Chemical Co., St. Louis, MO. Stock solutions of the purilevels of 1 ng/L or higher (up to 10, 000 ng/L) with a precision of fied compounds (10 02 or 10 03 M) were prepared in absolute ethanol. õ10%. All assays were performed in duplicate. Tissue culture superMore dilute solutions were also prepared in the same solvent. Bevernatants were measured undiluted using 100 mL aliquots per assay. ages (wine, tea and extracts) were used without further dilution.
Calculations. All tissue culture experiments were performed in Stimulation experiments. The steroid hormone receptor-positive quadruplicate and the results of PSA analysis are expressed as mean breast carcinoma cell line T-47D was obtained from the American { standard error of the mean (SEM). Percent (%) residual activity Type Culture Collection (ATCC), Rockville, MD. T-47D cells were of the stimulating steroid was calculated by dividing the concentracultured in RPMI media (Gibco BRL, Gaithersburg, MD) suppletion of PSA produced by the stimulating steroid in the presence of mented with glutamine (200 mM), bovine insulin (10 mg/L), fetal the candidate blocker, and the PSA concentration produced by the bovine serum (10%) and antibiotics (penicillin, streptomycin). The stimulating steroid in the absence of the candidate blocker, cells were cultured to near confluency in plastic culture flasks and multiplied by 100. Percent blocking was calculated by subtracting then transferred to phenol red-free media containing 10% charcoalthe % residual activity from 100. stripped fetal bovine serum with antibiotics. Phenol red-free media were used as phenol red was previously found to have weak estro-RESULTS genic activity (29) and charcoal-stripped fetal bovine serum is devoid of steroid hormones.
The T-47D cells were then aliquoted into 24-well tissue culture
We first examined if any of the compounds listed in plates and cultured to confluency with change in media at 3 days. Table 1 have agonist activity on the steroid hormone Stimulations were carried out with confluent cells containing 2 mL receptor system, as revealed by PSA production by the of phenol red-free media with 10% charcoal-stripped fetal calf serum cell lines T-47D and BT-474. Appreciable amounts of and antibiotics. Stimulation was initiated by adding 2 mL of each steroid, other compounds or natural products to be tested, either PSA were produced by both cell lines upon stimulation undiluted or diluted in 100% ethanol, and incubating for a certain by apigenin, naringenin and syringic acid. All other period of time (usually up to 8 days). Tissue culture supernatants compounds were inactive. The structures of these com-(Ç400 mL) were removed for PSA analysis. Appropriate multiple pounds are shown in Figure 1 potent since about the same concentration of PSA in ú50% of dihydrotestosterone action (control) but had minimal or no effect on either norgestimate (progestin; drotestosterone (Table 3) .
It is now realized that hormonally-dependent cancers Apigenin 17 95 are not associated with only one class of hormonal stim- trogens, progestins and androgens (30) . Consequently, the possible diverse activities of natural and xenobiotic compounds should be of interest, and investigations should not be limited to their estrogenic or antiestrotivity of compounds include the use of plasmids containing steroid hormone receptor response elements up-genic activity. In this respect, our study is unique since it has revealed novel biological agonist (progestational) stream of reporter genes (20, 36) . These systems may produce artificial results associated with the transfected and antagonist (antiprogestational/antiandrogen) activities of a number of natural compounds. plasmids and the multiplicity of the response elements that are usually present. A more preferable system in-
The extrapolation of our findings to human biological effects is difficult to evaluate since the data are derived cludes stimulation of untransfected cells and then monitoring of the endogenous regulation of an indicator gene with a tissue culture system and the details of absorption and pharmacokinetics of the majority of the tested at either the level of mRNA or protein. Estrogen upregulated genes used for this purpose include the progester-compounds are not known. Similar interpretitive difficulties were discussed by others for different naturally one receptor (20) and pS2 (21).
In our study, we focused on androgen-like and pro-occurring compounds. For example, Jang et al (19) reported anticarcinogenic activities of the trihydroxylstilgestin-like agonist and antagonist activity of a relatively large number of compounds (Table 1) . Such activ-bene resveratrol, while Gehm et al (20) proposed that this compound may, in fact, promote cancer due to its ity has not been examined in the past as most published studies have focused on estrogenic and antiestrogenic weak estrogenic activity. activity. Our experimental system includes two carcinoma cell lines which are steroid hormone receptorpositive. Once stimulated by a progestin or androgen, compounds appear to be weak progestins, acting at con-19. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F.,
In conclusion, our study contributes data on the posBeecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, sible biological activity of a number of natural com-D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997 
